Natera, Inc.

NTRA ·Healthcare, Medical Care Facilities, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-208.2M $-190.4M $-434.8M $-547.8M $-471.7M $-229.7M $-124.8M $-128.2M
Depreciation & Amortization $41.8M $31.0M $24.1M $16.7M $11.3M $8.6M $7.7M $7.5M
Depreciation $36.5M $27.2M $22.7M $16.7M $11.3M — — —
Amortization $3.9M $1.0M $0 — — — $1.2M $1.3M
Stock-Based Compensation $354.4M $274.4M $191.8M $152.4M $115.2M $50.2M $28.6M $14.2M
Net Cash from Operating Activities $215.3M $135.7M $-247.0M $-431.5M $-335.2M $-182.5M $-63.4M $-70.6M
Investing Activities
Capital Expenditures $106.2M $66.4M $39.2M $47.7M $41.0M $19.6M $5.0M $3.9M
Business Acquisitions $16.0M — — — $8.6M — — —
Net Cash from Investing Activities $-132.2M $137.6M $168.5M $330.3M $-205.2M $-331.5M $-266.4M $-5.2M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $47.5M $30.2M $254.5M $482.6M $576.2M $500.8M $340.8M $113.7M
Net Change in Cash — — — — — — — —
Free Cash Flow $109.1M $69.2M $-286.2M $-479.2M $-376.3M $-202.1M $-68.4M $-74.5M
← Newer Page 1 of 2 Older →